48,975
edits
Difference between revisions of "Intraductal carcinoma of the prostate"
Jump to navigation
Jump to search
Intraductal carcinoma of the prostate (view source)
Revision as of 14:54, 4 August 2022
, 14:54, 4 August 2022no edit summary
| (One intermediate revision by the same user not shown) | |||
| Line 119: | Line 119: | ||
==IHC== | ==IHC== | ||
Features - basal cells present: | Features - basal cells present: | ||
*CK34betaE12 +ve. | *[[CK34betaE12]] +ve. | ||
*p63 +ve. | *[[p63]] +ve. | ||
==Molecular== | ==Molecular== | ||
| Line 126: | Line 126: | ||
Note: | Note: | ||
*BRCA1 associated prostate cancer seems to be less common/less studied.<ref name=pmid29433453>{{cite journal | | *BRCA1 associated prostate cancer seems to be less common/less studied.<ref name=pmid29433453>{{cite journal |authors=Ibrahim M, Yadav S, Ogunleye F, Zakalik D |title=Male BRCA mutation carriers: clinical characteristics and cancer spectrum |journal=BMC Cancer |volume=18 |issue=1 |pages=179 |date=February 2018 |pmid=29433453 |pmc=5809938 |doi=10.1186/s12885-018-4098-y |url=https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4098-y }}</ref> | ||
==See also== | ==See also== | ||